Literature DB >> 25700601

Acid-suppressant therapy does not influence absorption of azoles used in candidemia.

Bruno Viaggi1, Carlo Tascini, Francesco Menichetti.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25700601     DOI： 10.1007/s00134-015-3691-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

2.  Inhibition of antifungal therapy by gastric acid suppressants.

Authors:  Harry W Daniell
Journal:  Intensive Care Med       Date:  2015-02-21       Impact factor: 17.440

3.  Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.

Authors:  Shellee A Grim; Karen Berger; Christine Teng; Sandeep Gupta; Jennifer E Layden; William M Janda; Nina M Clark
Journal:  J Antimicrob Chemother       Date:  2011-12-18       Impact factor: 5.790

4.  A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.

Authors:  Donald I Hsu; Megan Nguyen; Lee Nguyen; Anandi Law; Annie Wong-Beringer
Journal:  J Antimicrob Chemother       Date:  2010-06-16       Impact factor: 5.790

5.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.